After the protein minimization phase, CXCL12 and the CXCR4 peptide in each case were separated into different entries to treat CXCL12 as the receptor, and the CXCR4 peptide as a ligand for probing the binding free energy. The VSGB 2.0 implicit solvation model 4 of the Prime MM-GBSA module 1, 2 was used during the MM-GBSA calculations and polar hydrogens were minimized in order to retain the experimental conformations. The binding free energy was decomposed into per-residue binding free energy contribution on the peptide using the Prime energy visualizer module in Schrodinger's suite. 2 MM-GBSA calculation: ∆G bind = E complex (minimized) − (E ligand (minimized) + E receptor (minimized))
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Comparative binding energy analysis results. To gain additional insight into the properties of the I4/I6 binding site compared to other hotspots, and analyze its recognition epitopes on the CXCR4 peptide, we used Schrodinger Prime MM-GBSA 1, 2 to calculate the energetic contribution of each residue side chain on the receptor N-terminus to the PPI using the constitutively monomeric NMR CXCL12 (L55C/I58C) structure complexed to the non-sulfated N-terminal CXCR4 peptide (PDB ID: 2N55) (Fig. S1 ). Before the energetic contribution calculations, the experimentally determined structure was subjected to energy minimization as a complex and as individual proteins. The contribution of each residue side chain of the CXCR4 peptide to the binding energy was calculated considering interactions in both the complex state as well those in the free peptide. Based on these results, I4 is the residue contributing most to the binding of the non-sulfated N-terminus of CXCR4 to CXCL12 (Fig. S1) , consistent with the observation that I4 makes the most contacts in the NMR complex structure. However, I6 seems to contribute little to the binding energy despite its favorable contacts with CXCL12 in the complex state. This is potentially due to the energetic cost associated with the loss of favorable interactions in the free peptide state. Surprisingly, the Y12 and Y21 residues of the CXCR4 peptide do not appear to contribute favorably to the binding interaction ( and investigated whether the sulfation of Y12 and Y21 improved contributions to binding (Fig.   S1 ). Based on the calculations, both sY12 and sY21 contribute more favorably to binding than their non-sulfated counterparts in the CXCR4 peptide in complex with the constitutively monomeric CXCL12 (L55C/I58C) (Fig. S1 ). However, while the two calculations agree qualitatively with previous experimental results demonstrating the importance of O-sulfation, they also underestimate the significance of the sulfotyrosine residues' contributions to binding, and in particular for sY21. Close examination revealed structural differences between the protein conformations in the starting complex structure and the model post energy minimization, particularly for the CXCR4 peptide. Therefore it is possible that without the experimental restraints used for the modeling of the NMR structure the calculations were unable to accurately capture all of the interactions between CXCL12 and the CXCR4 peptide. . Novel small molecule ligand discovery using rigid docking. 2D 1 H-15 N HMQC spectroscopy identified three compounds that bound to WT-CXCL12 (1, 2, and 3) from the compounds chosen via rigid docking virtual screening. Chemical shifts for each compound were assigned and mapped to monomeric CXCL12 (PDB ID: 2N55). A docking prediction for each compound is included showing overlap between perturbed residues and the binding pocket. 
